Hello and welcome to the details of Ecuador signs agreement with Sinovac for two million Covid-19 vaccines, says minister and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
QUITO, Feb 26 ― The Ecuadorian government said yesterday it had negotiated the purchase of two million doses of Covid-19 vaccines with Chinese pharmaceutical company Sinovac, which would allow authorities to start a mass inoculation process in the coming weeks.
The Andean country began a pilot phase of vaccinations in January with doses of the Pfizer vaccine for medical personnel and elderly people in nursing homes, but has had delays in acquiring more doses.
“One million will arrive in March and the other (shipment) in April,” Health Minister Juan Carlos Zevallos told reporters.
With the Sinovac vaccine deal, the government now expects to receive around 20 million doses this year, enough to immunise 60 per cent of the population over 18 years of age.
The minister said that this month about 34,000 doses of Pfizer will also arrive, and starting in April, another 290,000 will arrive from the COVAX initiative, a program led by the World Health Organisation (WHO).
About 780,000 doses of the AstraZeneca vaccine are slated to arrive in May as part of a bilateral negotiation.
The Pfizer, AstraZeneca and Sinovac vaccines have all been authorized for use, Zevallos said.
Ecuador has registered about 279,000 infections and more than 10,800 deaths from the coronavirus. ― Reuters
These were the details of the news Ecuador signs agreement with Sinovac for two million Covid-19 vaccines, says minister for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.